Asensus Surgical (ASXC)
(Delayed Data from AMEX)
$0.25 USD
-0.01 (-3.85%)
Updated May 20, 2024 04:00 PM ET
After-Market: $0.24 -0.01 (-4.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Asensus Surgical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -78.43 | -75.56 | -62.46 | -59.31 | -154.20 |
Depreciation/Amortization & Depletion | 3.25 | 11.64 | 14.52 | 13.70 | 100.53 |
Net Change from Assets/Liabilities | 3.08 | -4.82 | 0.41 | -10.72 | -12.76 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 8.48 | 9.80 | 6.88 | 9.66 | -7.06 |
Net Cash From Operating Activities | -63.63 | -58.94 | -40.66 | -46.68 | -73.48 |
Property & Equipment | -0.56 | -1.28 | -1.37 | 0.00 | 15.53 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 65.07 | 48.82 | -118.30 | 0.00 | 52.12 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 64.51 | 47.54 | -119.67 | 0.00 | 67.65 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 10.12 | 0.02 | 162.77 | 50.67 | 26.32 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 2.82 | -31.43 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.50 | -0.35 | -1.06 | -0.11 | -0.50 |
Net Cash from Financing Activities | 9.63 | -0.33 | 161.71 | 53.37 | -5.61 |
Effect of Exchange Rate Changes | 0.76 | -0.08 | 0.38 | 0.27 | 0.36 |
Net Change In Cash & Equivalents | 11.27 | -11.81 | 1.75 | 6.96 | -11.08 |
Cash at Beginning of Period | 7.47 | 19.28 | 17.53 | 10.57 | 21.65 |
Cash at End of Period | 18.74 | 7.47 | 19.28 | 17.53 | 10.57 |
Diluted Net EPS | -0.31 | -0.32 | -0.28 | -0.85 | -8.69 |
Fiscal Year End for Asensus Surgical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -22.50 | -78.43 | -61.20 | -42.88 | -22.22 |
Depreciation/Amortization & Depletion | 0.94 | 3.25 | 2.29 | 1.58 | 0.84 |
Net Change from Assets/Liabilities | 0.48 | 3.08 | 3.91 | 1.36 | 2.40 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.07 | 8.48 | 4.74 | 4.74 | 1.74 |
Net Cash From Operating Activities | -14.01 | -63.63 | -50.25 | -35.20 | -17.25 |
Property & Equipment | 0.00 | -0.56 | -0.49 | -0.17 | -0.06 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 3.00 | 65.07 | 57.57 | 36.47 | 29.80 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 3.00 | 64.51 | 57.08 | 36.30 | 29.74 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.98 | 10.12 | 9.95 | 0.20 | 0.01 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.17 | -0.50 | -0.50 | -0.49 | -0.49 |
Net Cash from Financing Activities | 0.81 | 9.63 | 9.45 | -0.29 | -0.48 |
Effect of Exchange Rate Changes | -0.06 | 0.76 | -0.47 | 0.75 | 0.40 |
Net Change In Cash & Equivalents | -10.26 | 11.27 | 15.81 | 1.56 | 12.41 |
Cash at Beginning of Period | 18.74 | 7.47 | 7.47 | 7.47 | 7.47 |
Cash at End of Period | 8.48 | 18.74 | 23.28 | 9.03 | 19.88 |
Diluted Net EPS | -0.08 | -0.06 | -0.07 | -0.09 | -0.09 |